We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-11.3%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$18.9B
AUM Growth
-$2.79B
Cap. Flow
+$69.4M
Cap. Flow %
0.37%
Top 10 Hldgs %
29.85%
Holding
751
New
33
Increased
362
Reduced
288
Closed
53

Sector Composition

Rank Sector Weight
1 Materials 45.04%
2 Energy 26.72%
3 Healthcare 5.48%
4 Industrials 2.98%
5 Technology 2.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
126
Vertex Pharmaceuticals
VRTX
$121B
$29.1M 0.15%
258,671
-42,648
-14% -$4.06M
MDW
127
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$27.5M 0.15%
26,474,348
+5,181,873
+24% +$4.85M
FMC icon
128
FMC
FMC
$1.42B
$27.4M 0.15%
552,316
-295,019
-35% -$16.8M
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
$27.3M 0.14%
164,379
+16,272
+11% +$2.67M
CLD
130
DELISTED
Cloud Peak Energy Inc
CLD
$26.9M 0.14%
2,130,399
+12,668
+0.6% +$192K
CDE icon
131
Coeur Mining
CDE
$15.6B
$26M 0.14%
5,243,208
+254,091
+5% +$1.95M
REGN icon
132
Regeneron Pharmaceuticals
REGN
$68.8B
$24.9M 0.13%
69,165
-2,785
-4% -$933K
MRK icon
133
Merck
MRK
$324B
$23.5M 0.12%
414,992
+58,150
+16% +$3.27M
SNY icon
134
Sanofi
SNY
$104B
$22.8M 0.12%
403,217
+62,378
+18% +$3.35M
ILMN icon
135
Illumina
ILMN
$29.4B
$22.6M 0.12%
141,420
+12,070
+9% +$2.02M
MU icon
136
Micron Technology
MU
$1.04T
$22.5M 0.12%
655,376
+38,898
+6% +$1.26M
DRC
137
DELISTED
DRESSER-RAND GROUP INC
DRC
$22.4M 0.12%
271,948
-13,559
-5% -$911K
DRD
138
DRDGold
DRD
$1.82B
$22.1M 0.12%
6,510,655
+2,216,940
+52% +$6.29M
IWO icon
139
iShares Russell 2000 Growth ETF
IWO
$14.5B
$21.6M 0.11%
166,469
+2,358
+1% +$316K
ASML icon
140
ASML
ASML
$675B
$21.3M 0.11%
215,380
-2,629
-1% -$247K
TXN icon
141
Texas Instruments
TXN
$255B
$20.9M 0.11%
438,609
+38,577
+10% +$1.85M
GPL
142
DELISTED
Great Panther Mining Limited
GPL
$20.9M 0.11%
2,044,110
+348,259
+21% +$4.21M
NVO
143
Novo Nordisk
NVO
$216B
$20.8M 0.11%
873,386
+115,198
+15% +$2.65M
CRR
144
DELISTED
Carbo Ceramics Inc.
CRR
$20.6M 0.11%
347,406
-304,000
-47% -$34.7M
VEON icon
145
VEON
VEON
$3.53B
$20.5M 0.11%
113,813
+34,568
+44% +$7.27M
PTEN icon
146
Patterson-UTI
PTEN
$3.87B
$20.3M 0.11%
622,709
-22,760
-4% -$773K
BMRN icon
147
BioMarin Pharmaceuticals
BMRN
$11.5B
$19.6M 0.1%
272,162
-2,554
-0.9% -$168K
NLY icon
148
Annaly Capital Management
NLY
$16.9B
$19.6M 0.1%
458,006
+5,436
+1% +$248K
GSK icon
149
GSK
GSK
$103B
$19.5M 0.1%
339,529
+91,435
+37% +$5.61M
BRCM
150
DELISTED
BROADCOM CORP CL-A
BRCM
$18.8M 0.1%
465,609
+13,022
+3% +$506K

Similar funds

VanEck Associates's Q3 2014 Portfolio in Review

As of Q3 2014, VanEck Associates held 751 positions worth $18.9B, down 13% from $21.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

VanEck Associates's Q3 2014 filing shows 33 new, 362 increased, 288 reduced and 53 closed positions. Its largest new stake was VanEck Gold Miners ETF: 3,917,124 shares worth $83.7M. The largest sale was Nebius Group N.V., an estimated $73.2M.

By sector, the portfolio is most concentrated in Materials at 45% of assets, down from 45% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q3 2014 buy was VanEck Gold Miners ETF: 3,917,124 shares worth $83.7M.
  • VanEck Associates added most to APA Corp in Q3 2014, an estimated $112M increase.
  • VanEck Associates's biggest Q3 2014 reduction was Potash Corp Of Saskatchewan, cutting an estimated $55.7M.
  • VanEck Associates fully exited Nebius Group N.V. in Q3 2014, selling an estimated $73.2M.
  • VanEck Associates's ten largest holdings make up 30% of its $18.9B portfolio in Q3 2014.
  • VanEck Associates opened 33 new positions and closed 53 in Q3 2014.
  • VanEck Associates's portfolio value fell 13% quarter-over-quarter to $18.9B.

Based on VanEck Associates's 13F filing for Q3 2014, filed 14 Nov 2014.